Skip to main content

Advertisement

SpringerLink
Log in

Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Twelve non-small cell lung carcinomas and adjacent normal lung tissues were examined for mutations of the nm23-H1 gene by using SSCP analysis and for an expression of the nm23-H1 protein by immunohis-tochemistry. No mutations could be found in either the carcinomas or in the adjacent normal tissues. In contrast, six of 12 carcinomas showed protein expression while only one adjacent normal lung tissue yielded a positive staining result. Therefore, the expression of nm23-H1 protein was analysed in a larger group of non-small cell lung carcinomas (n = 185) to determine whether or not the expression of nm23 protein may be of prognostic relevance. Only a weak relationship between nm23-H1 expression and lymph node involve-ment was observed. However, a significant correlation between proliferation and nm23-H1 expression was detected. Additionally, a direct correlation between apoptosis and nm23-H1 expression or between myc and nm23-H1 expression was found. Finally, non-small cell lung carcinomas that expressed nm23-H1 protein were more frequently sensitive to doxorubicin than carcinomas that did not express this protein. ©Lippincott Williams & Wilkins

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steeg PS, Bevilacqua G, Kopper L, et al.,1988, Evidence of a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 80, 200-4.

    Google Scholar 

  2. Postel EH, Berberich SJ, Flint SJ and Ferrone CA, 1993, Human c-myctranscription factor puF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261, 478-80.

    Google Scholar 

  3. Royds JA, Robinson MH, Stephenson TJ, Rees RC and Fisher C, 1997, The association between nm23 gene expression and survival in patients with sarcomas. Br J Cancer, 75, 1195-200.

    Google Scholar 

  4. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS, 1989, Association of low nm23 RNA levels in primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res, 49, 5185-90.

    Google Scholar 

  5. Hennessy C, Henry JA, May FEB, Westley BR, Angus B and Lennard TWJ, 1991, Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst,83, 281-5.

    Google Scholar 

  6. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS and Fodstad O, 1992, Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res,52, 6088-91.

    Google Scholar 

  7. Leone A, Seeger RC, Hong CM, et al.,1993, Evidence for nm23 RNA expression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8, 855-65.

    Google Scholar 

  8. Luo W, Matsuo K, Nagayama Y, et al.,1994, Immunohistochemical analysis of expression of nm23H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Thyroid, 3, 105-9.

    Google Scholar 

  9. Engel M, Theisinger B, Seib T, et al.,1993, High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer, 55, 375-9.

    Google Scholar 

  10. Higashiyama M, Doi O, Yokouchi H, et al.,1992, Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma. Lack of prognostic value. Br J Cancer, 66, 533-6.

    Google Scholar 

  11. Ozeki Y, Takishima K and Mamiya G, 1994, Immunohistochemical analysis of nm23 / NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type. Jpn J Cancer, 85, 840-6.

    Google Scholar 

  12. Gazzeri S, Brambilla E, Negoescu A, et al.,1996, Overexpression of nucleoside diphosphate/kinase A / nm23-H1 protein in human lung tumors. Association with tumor progression in squamous carcinoma. Lab Invest, 74, 158-67.

    Google Scholar 

  13. Kawakubo Y, Sato Y, Koh T, Kono H and Kameya T, 1997, Expression of nm23 protein in pulmonary adenocarcinomas: inverse correlation to tumor progression. Lung Cancer, 17, 103-13.

    Google Scholar 

  14. World Health Organization, 1981, Histological typing of lung tumors. Tumori, 6, 253-72.

    Google Scholar 

  15. Carr DT and Mountain CF, 1977, Staging lung cancer. In: Strauss MJ, ed. Lung Cancer: Clinical Diagnosis and Treatment. Grune and Stratton, New York, pp. 151-61.

    Google Scholar 

  16. Schneider J, Rubio MP, Rodriquez-Escudero FJ, Seizinger BR and Castresana JS, 1994, Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: Comparison with the results of immunohistochemistry. Eur J Cancer, 30A, 504-8.

    Google Scholar 

  17. Bafico A, Varesco L, De Benedetti L, et al.,1993, Genomic PCR-SSCP analysis of the metastasis associated nm23-H1 (NME1) gene: a study on colorectal cancer. Anticancer Res, 13, 2149-54.

    Google Scholar 

  18. Volm M, Mattern J and Samsel B, 1993, Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein and glutathione S-transferase π in human lung tumors. Cancer, 71, 3181-7.

    Google Scholar 

  19. Hartsough MT, Frey RS, Zipfel PA, et al.,1996, Altered transforming growth factor β signaling in epithelial cells when ras activation is blocked. J Biol Chem, 37, 22368-75.

    Google Scholar 

  20. Roos G, Landberg G, Huff G, Houghten P, Takasaki Y and Tan EM, 1993, Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab Invest, 68, 204-10.

    Google Scholar 

  21. Efferth T and Volm M, 1992, Immunocytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance. Cancer Detect Prev, 4, 237-43.

    Google Scholar 

  22. Stammler G and Volm M, 1996, Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis. Apoptosis, 1, 95-9.

    Google Scholar 

  23. Volm M, Wayss K, Kaufmann M and Mattern J, 1979, Pretherapeutic detection of tumor resistance and the results of tumor chemotherapy. Eur J Cancer, 15, 983-93.

    Google Scholar 

  24. Group for Sensitivity Testing of Tumors (KSST), 1981, In vitroshort-term test to determine the resistance of human tumors to chemotherapy. Cancer, 48, 2127-35.

    Google Scholar 

  25. Fleiss JL, 1973, Statistical Methods for Rates and Proportion. Wiley, New York.

    Google Scholar 

  26. Hall PA and Levison DA, 1990, Review: assessment of cell proliferation in histological material. J Clin Pathol, 43, 184-92.

    Google Scholar 

  27. Hall PA and Woods AL, 1990, Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet, 23, 505-22.

    Google Scholar 

  28. Jaskulski D, De Riel JK, Mercer WE, Calabretta B and Baserga R, 1988, Inhibition of cellular proliferation by antisense oligonucleotides to PCNA/cyclin. Science, 240, 1544-6.

    Google Scholar 

  29. Garcia RL, Coltrera MD and Gown AM, 1989, Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol, 134, 733-9.

    Google Scholar 

  30. Cordon-Cardo C, 1995, Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia (review). Am J Pathol, 147, 545-60.

    Google Scholar 

  31. Paterlini P, Flejou JF, De Mitri MS, Pisi E, Franco D and Brechot C, 1995, Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with low cytometric parameters. J Hepatol,23, 47-52.

    Google Scholar 

  32. Volm M, Koomägi R, Mattern J and Stammler G, 1997, Cyclin A is associated with an unfavourable outcome in patients with non-small cell lung carcinomas. Br J Cancer, 75, 1774-8.

    Google Scholar 

  33. Venturelli D, Martinez R, Melotti P, et al.,1995, Overexpression of DR-nm23, a protein encoded by a member of the nm23gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci USA, 92, 7435-9.

    Google Scholar 

  34. Hickman JA, 1996, Apoptosis and chemotherapy resistance. Eur J Cancer, 32A, 921-6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncological Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany

    Manfred Volm, Jurgen Mattern & Reet Koomugi

Authors
  1. Manfred Volm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jurgen Mattern
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reet Koomugi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volm, M., Mattern, J. & Koomugi, R. Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis 16, 595–602 (1998). https://doi.org/10.1023/A:1006588601683

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006588601683

Search

Navigation